Literature DB >> 26284608

Conjugation of Ciprofloxacin with Poly(2-oxazoline)s and Polyethylene Glycol via End Groups.

Martin Schmidt1, Simon Harmuth1, Eva Rebecca Barth1, Elena Wurm1, Rita Fobbe2, Albert Sickmann2, Christian Krumm1, Joerg C Tiller1.   

Abstract

The antibiotic ciprofloxacin (CIP) was covalently attached to the chain end of poly(2-methyloxazoline) (PMOx), poly(2-ethyloxazoline) (PEtOx), and polyethylene glycol (PEG), and the antimicrobial activity of these conjugates was tested for Staphylococcus aureus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, and Kleisella pneumoniae. Chemical structures of the conjugates were proven by (1)H NMR and electron spray ionization mass spectrometry. The direct coupling of PMOx and CIP resulted in low antimicrobial activity. The coupling via a spacer afforded molecular weight dependent activity with a molar minimal inhibitory concentration that is even higher than that of the pristine CIP. The antimicrobial activity of the conjugates increases in the order of PMOx < PEtOx < PEG. Conjugation of CIP and a quaternary ammonium compound via PMOx did not result in higher activity, indicating no satellite group or synergistic effect of the different biocidal end groups.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284608     DOI: 10.1021/acs.bioconjchem.5b00393

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  10 in total

1.  Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities.

Authors:  Azeza Falghoush; Haluk Beyenal; Thomas E Besser; Anders Omsland; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

2.  Small antibacterial molecules highly active against drug-resistant Staphylococcus aureus.

Authors:  Rajib Dey; Kathakali De; Riya Mukherjee; Sreyan Ghosh; Jayanta Haldar
Journal:  Medchemcomm       Date:  2019-07-30       Impact factor: 3.597

3.  Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications.

Authors:  Islam A Khalil; Bahram Saleh; Dina M Ibrahim; Clotilde Jumelle; Ann Yung; Reza Dana; Nasim Annabi
Journal:  Biomater Sci       Date:  2020-09-15       Impact factor: 6.843

4.  Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.

Authors:  Jesus Magallon; Kevin Chiem; Tung Tran; Maria S Ramirez; Veronica Jimenez; Marcelo E Tolmasky
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

5.  Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake.

Authors:  Guowei Wang; Qunying Li; Danfei Chen; Bihan Wu; Yulian Wu; Weijun Tong; Pintong Huang
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

6.  Poly(2-oxazoline)s with a 2,2'-Iminodiacetate End Group Inhibit and Stabilize Laccase.

Authors:  Montasser Hijazi; Esra Türkmen; Joerg C Tiller
Journal:  Chembiochem       Date:  2019-12-13       Impact factor: 3.164

7.  Full Thermal Switching of Enzymes by Thermoresponsive Poly(2-oxazoline)-Based Enzyme Inhibitors.

Authors:  Montasser Hijazi; Esra Türkmen; Joerg C Tiller
Journal:  Chemistry       Date:  2020-09-23       Impact factor: 5.236

8.  Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections.

Authors:  Alka Agarwal; Preeti Singh; Anand Maurya; Upendra Kumar Patel; Alka Singh; Gopal Nath
Journal:  ACS Omega       Date:  2022-01-11

9.  Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis.

Authors:  Pietro Picconi; Rose Jeeves; Christopher William Moon; Shirin Jamshidi; Kazi S Nahar; Mark Laws; Joanna Bacon; Khondaker Miraz Rahman
Journal:  ACS Omega       Date:  2019-12-03

10.  Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline).

Authors:  See Yee Fam; Chin Fei Chee; Chean Yeah Yong; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Han Yih Lau; Wen Siang Tan
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.